GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Street Capital Inc (OTCPK:REZNF) » Definitions » EV-to-EBITDA

REZNF (Street Capital) EV-to-EBITDA : -7.87 (As of May. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Street Capital EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Street Capital's enterprise value is $1.14 Mil. Street Capital's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.15 Mil. Therefore, Street Capital's EV-to-EBITDA for today is -7.87.

The historical rank and industry rank for Street Capital's EV-to-EBITDA or its related term are showing as below:

REZNF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -8.07   Med: -3.38   Max: -0.24
Current: -8.07

During the past 5 years, the highest EV-to-EBITDA of Street Capital was -0.24. The lowest was -8.07. And the median was -3.38.

REZNF's EV-to-EBITDA is ranked worse than
100% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.73 vs REZNF: -8.07

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-25), Street Capital's stock price is $0.01015. Street Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.000. Therefore, Street Capital's PE Ratio (TTM) for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Street Capital EV-to-EBITDA Historical Data

The historical data trend for Street Capital's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Street Capital EV-to-EBITDA Chart

Street Capital Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - -0.86 -1.30 -6.19

Street Capital Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.39 -6.19 -4.61 -7.02 -8.07

Competitive Comparison of Street Capital's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Street Capital's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Street Capital's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Street Capital's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Street Capital's EV-to-EBITDA falls into.


;
;

Street Capital EV-to-EBITDA Calculation

Street Capital's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.141/-0.145
=-7.87

Street Capital's current Enterprise Value is $1.14 Mil.
Street Capital's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Street Capital  (OTCPK:REZNF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Street Capital's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01015/0.000
=N/A

Street Capital's share price for today is $0.01015.
Street Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Street Capital EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Street Capital's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Street Capital Business Description

Traded in Other Exchanges
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Street Capital Inc formerly The Hash Corp is engaged in the production and sale of cannabis-based hashish and other cannabis products. It applies its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additive and carcinogenic solvents.

Street Capital Headlines

No Headlines